Anjan Drug Private Limited - pharma in Chengalpattu Dt, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U24231TN1990PTC019461 Incorporated 01 August 1990 ROC Chennai HQ Chengalpattu Dt, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹293.42 Cr
▼ 14.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹26.1 Cr
Registered with MCA
Paid-up capital
₹5.88 Cr
Issued & subscribed
Open charges
₹92.9 Cr
Satisfied ₹295.76 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
297
Latest available

About Anjan Drug Private Limited

Data last updated: 17 December 2025

Anjan Drug Private Limited is a private limited company based in Chengalpattu Dt, Tamil Nadu, India, a subsidiary of Sekhmet Pharmaventures Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 01 August 1990, the company has been in operation for over 36 years.

Registered with ROC Chennai under CIN U24231TN1990PTC019461.

Capital: an authorised share capital of ₹26.1 Cr and a paid-up capital of ₹5.88 Cr. Formerly known as Anjan Drugs Private Limited. It is led by directors including Anil Khubchandani and Lakshay Kataria.

Last AGM: 30 December 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No.109 & 116 Sidcopharmaceutical I Estate Alathur – 603 110, Chengalpattu Dt, Tamil Nadu, India – 603110.

As per the financials filed for FY 2025, the company reported a revenue of ₹293.42 Cr, a decline of 14% compared to the previous year.

The company has a workforce of approximately 297 employees as per the latest available data. It operates as a subsidiary of Sekhmet Pharmaventures Private Limited.

The company is associated with 1 brand - Anjan Drug. As per MCA filings, the company has open charges of ₹92.9 Cr and satisfied charges of ₹295.76 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anjandrug.net.

Company Details of Anjan Drug Private Limited
CIN U24231TN1990PTC019461
Registration Number 019461
Incorporation Date 01 August 1990
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 December 2024
Date of Balance Sheet 31 March 2024
Parent Company Sekhmet Pharmaventures Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Plot No.109 & 116 Sidcopharmaceutical I Estate Alathur – 603 110, Chengalpattu Dt, Tamil Nadu, India – 603110
  • Industry
    Pharma, API Manufacturers
Company report
Anjan Drug Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Anjan Drug Private Limited report

Financials, compliance, directors, charges, ownership and filings for Anjan Drug Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Anjan Drug Private Limited

Anjan Drug Private Limited operates one associated brand: Anjan Drug. These brands represent Anjan Drug Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Active pharmaceutical ingredients for CNS disorders are manufactured. anjandrug.net

Competitors & Alternatives of Anjan Drug Private Limited

Brands and companies operating in the same space as Anjan Drug Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Anjan Drug Private Limited

Anjan Drug Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Anjan Drug Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Anjan Drug Private Limited

Anjan Drug Private Limited is audited by BSR & CO. LLP, for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
BSR & CO. LLP, Locked Locked Locked
Premium access

Complete auditor history for Anjan Drug Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Anjan Drug Private Limited

Anjan Drug Private Limited is currently managed by 8 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Anil Khubchandani Director 12 Oct 2023 2 Years 9 Months Current
Lakshay Kataria Additional Director 01 Apr 2025 1 Years 3 Months Current
Pagadala Baskarannarayanan Director 11 Jan 2023 3 Years 6 Months Current
Vivek Chhachhi Nominee Director 09 Oct 2020 5 Years 9 Months Current
Chinnannan Kalaichelvan Director 01 Aug 1990 35 Years 11 Months Current
Santosh Kumar Mahil Director 26 Jun 2025 1 Years 0 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Anjan Drug Private Limited FY 2024 filings available

Anjan Drug Private Limited reported revenue of ₹293.42 Cr (down 14.00% YoY) for FY 2025.

Revenue · FY 2025
₹293.42 Cr ▼ 14.00%
Premium access

Ten-year financial statements for Anjan Drug Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Anjan Drug Private Limited

Premium access

Shareholding and ownership data for Anjan Drug Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Anjan Drug Private Limited

Open charges
₹92.9 Cr
Satisfied charges
₹295.76 Cr
Breakdown by lending institutions
Axis Bank Limited₹31.70 Cr
Hdfc Bank Limited₹31.20 Cr
Others₹30.00 Cr
Latest charge details
DateLenderAmountStatus
07 Mar 2022 Others ₹15 Cr Open
21 Oct 2021 Hdfc Bank Limited ₹31.2 Cr Open
01 Jun 2021 Others ₹15 Cr Open
22 Apr 2021 Axis Bank Limited ₹31.7 Cr Open
09 Jun 2022 Hdfc Bank Limited ₹14.5 Cr Satisfied

Total charge records: 21 View all charges

Employees and EPFO Compliance at Anjan Drug Private Limited

Anjan Drug Private Limited has a workforce of 297 employees as of Apr 07, 2024.

Employee count
297
Active EPFO establishments
1
Employee growth
4.58%
Premium access

Employee and EPFO history for Anjan Drug Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Anjan Drug Private Limited

Premium access

GST registrations and filing compliance for Anjan Drug Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Anjan Drug Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Anjan Drug Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Anjan Drug Private Limited

Premium access

MSME payment history for Anjan Drug Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Anjan Drug Private Limited

Premium access

Corporate group structure for Anjan Drug Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Anjan Drug Private Limited

Premium access

MCA filings and documents for Anjan Drug Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Anjan Drug Private Limited

Directors
16 Jul 2025
Devi Thumati Krishnaraj was appointed as a Officer in default on 16 Jul 2025 & has been associated with this company since 11 months 28 days.
Directors
26 Jun 2025
Santosh Kumar Mahil was appointed as a Director on 26 Jun 2025 & has been associated with this company since 1 year 17 days.
Directors
01 May 2025
Sumit Mohan Nadgir was appointed as a Director on 01 May 2025 & has been associated with this company since 1 year 2 months.
Directors
01 Apr 2025
Lakshay Kataria was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
30 Dec 2024
Anjan Drug Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records.
Activity
31 Mar 2024
Anjan Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

Recent News on Anjan Drug Private Limited

PAG to pick minority stake in RK Pharma
05 Jun 2023 · Livemint

Frequently Asked Questions about Anjan Drug Private Limited

Anjan Drug Private Limited is an active private limited company in the pharma sector based in Chengalpattu Dt, Tamil Nadu, India. It was incorporated on 01 August 1990 (36+ years old) and is registered under CIN U24231TN1990PTC019461. The company has 297 employees.

Anjan Drug Private Limited reported revenue of ₹293.42 Cr for FY 2025 (down 14.00% YoY).

The current directors of Anjan Drug Private Limited are:

The primary industry of Anjan Drug Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Anjan Drug Private Limited can be reached at the registered office: Plot No.109 & 116 Sidcopharmaceutical I Estate Alathur – 603 110, Chengalpattu Dt, Tamil Nadu, India – 603110, or through the website anjandrug.net.

The authorised capital is ₹26.1 Cr, and the paid-up capital is ₹5.88 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available